Article from Brazil
Jul 17, 2019 9:58:25 GMT -5
via mobile
edvarney, esstan2001, and 7 more like this
Post by mnholdem on Jul 17, 2019 9:58:25 GMT -5
Link: www.google.com/amp/s/www.correio24horas.com.br/amp/nid/diabetico-sim-fitness-tambem-pacientes-encaram-atividade-fisica-como-tratamento-para-doenca/
Excerpts (translated to English):
New forms of treatment seek to give more options. Last week, the National Agency of Sanitary Surveillance (Anvisa) approved the commercialization of Afrezza, a fast acting inhalation insulin. Biomm, which has the product rights in the country, estimates that the sale will start from the fourth quarter of the year.
Inhaled insulin comes as an alternative to the injectable, but not to replace it. The rapid type version is used near meals and should be used with slow acting insulin, which controls glucose for long periods. The powder is placed in the inhaler, aspirated and absorbed by the body in seconds. It is suitable for type 1 and type 2 diabetics and is not recommended for children or people with respiratory problems.
Excerpts (translated to English):
New forms of treatment seek to give more options. Last week, the National Agency of Sanitary Surveillance (Anvisa) approved the commercialization of Afrezza, a fast acting inhalation insulin. Biomm, which has the product rights in the country, estimates that the sale will start from the fourth quarter of the year.
Inhaled insulin comes as an alternative to the injectable, but not to replace it. The rapid type version is used near meals and should be used with slow acting insulin, which controls glucose for long periods. The powder is placed in the inhaler, aspirated and absorbed by the body in seconds. It is suitable for type 1 and type 2 diabetics and is not recommended for children or people with respiratory problems.
